FDA Approves New Drug to Reduce Risk of Stroke

Circulation - United States
doi 10.1161/01.cir.101.3.e41
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy